SIRT1 and subarachnoid hemorrhage: Notably, the administration of the potent SIRT1 inhibitor sirtinol (SIR) hampers SIRT1 activation, reverses the aforementioned protein expression and outcomes, and exacerbates brain edema following experimental subarachnoid hemorrhage [136, 137, 160].